87
Participants
Start Date
November 30, 2005
Primary Completion Date
February 28, 2006
Study Completion Date
February 28, 2006
AL-37807 Ophthalmic Suspension, 1.0%
One drop in the study eye(s) once daily for 28 days
Latanoprost, 0.005% (Xalatan)
One drop in the study eye(s) once daily for 28 days
AL-37807 Vehicle
One drop in the study eye(s) once daily for 28 days
Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%
One drop in the study eye(s) once daily for 28 days
United States Investigative Sites in Texas and Other States, Fort Worth
Lead Sponsor
Alcon Research
INDUSTRY